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Staphylococcus aureus Among Patients Admitted
to Two Healthcare Facilities in Algeria
Ferhat Djoudi,1 Said Benallaoua,1 Aurora Aleo,2 Abdelaziz Touati,3
Mouloud Challal,1 Celestino Bonura,2 and Caterina Mammina2
Aim: To evaluate nasal carriage rate and variables associated with Staphylococcus aureus and methicillin-
resistant Staphylococcus aureus (MRSA) in patients admitted in two healthcare facilities. Results: S. aureus
was isolated from 159 (26%) of the enrolled patients. Methicillin-susceptible S. aureus was isolated from 150
(24.5%) patients, and MRSA was isolated from 9 (1.5%). Cancer and previous hospitalization were associated
with a significantly higher frequency of nasal S. aureus carriage among the patients admitted to the general
hospital and the nephrology department, respectively. MRSA isolates were heterogeneous with respect to their
staphylococcal cassette chromosome mec element (SCCmec) type, sequence type (ST), and toxin genes ( pvl
and tst1) content. Four isolates were attributed with the ST80-MRSA-IV clone, which is known to be pre-
dominant in Algeria. Conclusions: This is the first assessment of S. aureus and MRSA nasal carriage and
associated variables in Algeria. Our findings provide also a picture of the MRSA strains circulating in the
community in this geographic area. They can be useful as a guide for implementing screening and control
procedures against S. aureus/MRSA in the Algerian healthcare facilities.
Introduction
Staphylococcus aureus is a remarkably versatilepathogen able to cause several infections, produce a
large arsenal of virulence factors, escape the defenses of the
human organism, and survive also in harsh conditions.
S. aureus causes a wide range of syndromes, from minor
skin and soft tissue infections to life-threatening sepsis and
toxic shock syndrome.12,36 S. aureus, indeed, adheres and in-
vades host epithelial cells using a variety of molecules col-
lectively named MSCRAMM (microbial surface components
recognizing adhesive matrix molecules).12,29,36 Additional
factors are responsible for destruction of tissues and cells, in-
cluding immune cells. Exotoxins, such as the Panton-Valentine
leukocidin (PVL), play also a determinant role.12 Indeed, the
presence of such a virulence factor can significantly increase
the morbidity due to this pathogen, especially in geographical
areas where the prevalence of PVL-positive strains is high, as
it has been recently reported in Algeria.6,7 Other alarming
features are the high prevalence of methicillin resistance
rates within the S. aureus strains in some countries, and the
emergence of community-associated methicillin-resistant
S. aureus (MRSA) infections in otherwise healthy patients.3
S. aureus is a commensal organism that can colonize
several sites without causing infection in its host. The an-
terior nares are the main ecological niche for S. aureus. As
much as 20% of individuals are reported to be persistently
nasally colonized with S. aureus, and a further 30% can be
intermittently colonized.12,29 Bacteria that reside in anterior
nares play a role of both reservoir for the spread of this
pathogen and risk condition for subsequent infection.3,12,33
It is, well established that carriage increases the infection
risk.18,36 Habitually, it is indeed the colonizing strain that is
involved in the infection, according to a study on bacter-
emias where blood isolates were identical to the nasal ones
in 82% of patients.33 The carrier status can be promoted by
several factors, including patient’s age and immunological
status, recent hospitalization, antimicrobial drug treatment,
and underlying disease.18,22,29,36 Most of these factors are
frequently encountered in the subjects admitted to hospital.
MRSA and, in particular, the so-called European clone
ST80-MRSA-IV, is recognized as a prevalent etiological
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agent of infection in Algeria,6,7 however, no study has been
previously carried out on nasal carriage in this country. This
study was conducted in two healthcare facilities in Bejaia,
Algeria, to determine the prevalence and epidemiological and
clinical variables associated with carriage of S. aureus and
MRSA in patients sampled at the time of hospital admission.
Molecular typing of the MRSA isolates was also performed.
Materials and Methods
Setting
This study was carried out during a period of 27 months
in two healthcare facilities in the region of Bejaia, Algeria,
both serving about one million population: the first one was
the Frantz-Fanon nephrology department with a capacity of
32 beds, comprising also a hemodialysis ward, and the
second was the Amizour 240-bed acute general hospital,
including wards of pediatrics, surgery, oncology, internal
medicine, emergency, and intensive care unit.
Subjects and data collection
All patients who were admitted from April 1, 2010 to June
30, 2012, and gave their consent to nasal swabbing within 48
hours from their admission, were enrolled. Patient data were
collected from hospital charts. They included demographics,
ward of admission, underlying disease, reason for admission,
history of previous hospitalization and antibiotic treatment
during the last 6 months, presence of a familymember working
in healthcare setting, recent surgery, and smoking habits.
Microbiological methods
Specimens were taken with sterile nasal swabs introduced
in each nostril to a depth of *1 cm and rotated five times.
Giolitti-Cantoni broth was used as the transport medium. The
samples were quickly sent to the laboratory, where mannitol-
salt agar plates were inoculated and incubated at 37C for 48
hours. Identification of S. aureus was based on morphology,
Gram stain, catalase test, mannitol fermentation, and coag-
ulase test with rabbit plasma. MRSA isolates were detected
by plating S. aureus colonies onto Mueller-Hinton agar
screen plates containing 6mg/ml oxacillin with 4% NaCl.
The presence of the mecA gene was confirmed by PCR.
Antibiotic susceptibility determination
Susceptibility of the MRSA isolates was tested against 12
antimicrobial agents using the disk diffusion method ac-
cording to the guidelines of the Clinical Laboratory Stan-
dards Institute.4 The antibiotics tested were cefoxitin (30mg),
ciprofloxacin (5mg), tobramycin (10mg), clindamycin (2mg),
erythromycin (15mg), gentamicin (10mg), linezolid (30mg),
rifampicin (5mg), tetracycline (30mg), teicoplanine (30mg),
trimethoprim-sulfamethoxazole (1.25/23.75mg), and vanco-
mycin (30mg). S. aureus American Type Culture Collection
(ATCC) 29213 was used as a quality control strain.
Molecular typing
All methicillin-resistant isolates were examined by the
following molecular methods:
SCCmec typing and SCCmec type IV subtyping. Multi-
plex PCR was performed to identify the staphylococcal
cassette chromosome mec element (SCCmec) types I to
VI,24 or by a second method if not typeable by the first
one,19 and results were interpreted according to the guide-
lines of International Working Group on the Staphylococcal
Cassette Chromosome elements (www.sccmec.org). PCR
products were then visualized on 3% Tris-Borate-EDTA
agarose gels. To distinguish between the different SCCmec
IV subtypes, a further multiplex PCR was performed as
previously described.23 An ST22-MRSA-IVa, which had
been previously isolated in Palermo, Italy, and had been
fully characterized at the Staten Serum Institut, Copenha-
gen, Denmark, was used as a reference strain.11 Identity of
SCCmec VII was confirmed by sequencing and comparison
with the sequence deposited in the GenBank database by
Takano et al.30 (www.ncbi.nlm.nih.gov/nuccore/AB462393.1)
Multiple loci variable number tandem repeat fingerprint-
ing. Multiple loci variable number tandem repeat finger-
printing (MLVF) analysis was performed according to a
method previously described to assess possible clonality
among strains isolated from different patients.28 Electro-
phoresis of the PCR products was performed in Tris-borate
buffer 0.5 · - 2% agarose gel. The banding patterns were
compared visually.
Multilocus sequence typing and spa typing. To define the
sequence types (ST) of MRSA strains, multilocus sequence
typing (MLST) was performed as previously and strains were
assigned to STs using the MLST database (http://saureus
.mlst.net/).8 spa typing was also carried out on the MRSA-
ST22-IVa isolates using the Ridom StaphType software
(www.ridom.de/staphtype/).
pvl and tst1 genes detection. The presence of pvl (lukF-
PV and lukS-PV) and tst1 genes was investigated as previ-
ously described and the PCR products were analyzed by
electrophoresis on 1.5% agarose gel.15
Ethical considerations
Informed oral consent was obtained from all patients prior
to specimen collection. Ethical considerations were taken
into account during all steps of the study. The study results
were entered and maintained in a secure database.
Statistical analysis
The statistical analysis was performed by calculating the
means and frequencies and the significance of differences was
assessed by one-way ANOVA test or Kruskall–Wallis, when
appropriate, or by the chi-square test or the Fisher’s exact test,
respectively. The associations between the variables under ex-
amination were evaluated using contingency tables. All reported
p-valueswere two-sided and p<0.05was considered significant.
Results
During the 27-month study period, 612 patients were en-
rolled: 105 patients were admitted to the Frantz-Fanon ne-
phrology department, and 507 to the Amizour acute general
hospital. Two hundred thirty-eight patients were male (male/
female ratio, 63.6%). No ethnic differences were observed
among the studied population. Twenty subjects were 0–14
year-old. The median age was 53.5 years (interquartile range
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[IQR] 38.0–67.5 years) with no significant differences be-
tween the patients admitted to the two healthcare facilities
(Amizur hospital vs. nephrology department [54.0 (IQR, 38.0–
68.0) vs. 48.5 (IQR, 36.0–64.0), p= 0.49]).
One hundred fifty-nine (26%) out of the 612 patients under
investigation were found to carry S. aureus. In particular, a
significantly higher proportion of patients admitted to the
nephrology department proved to be colonized compared to
the patients admitted to the acute general hospital (55 out of
105 [52.5%] vs. 104 out of 507 [20.5%], p< 0.001). In both
subgroup of patients, the median age of colonized patients was
not significantly different from that of noncolonized patients
(Amizur hospital, colonized vs. no colonized patients, 52
years [IQR 38.5–64] vs. 55 years [IQR 38–69], p= 0.38; ne-
phrology department, colonized vs. no colonized patients, 52
years [IQR 36–64] vs. 46 years [IQR 35–68], p= 0.81).
Carriage rates, epidemiological and clinical features of
the enrolled patients are shown in Table 1. Within patients
Table 1. Staphylococcus aureus Carrier Status of the Study Patients Admitted
to Two Healthcare Institutions in Algeria (April 2010 to June 2012)
S. aureus nasal carriage
Patient characteristic General hospital n = 507 p Nephrology department n = 105 p
Gender
Male 45 (21.1%) 0.25 25 (58.1%) 0.32
Female 59 (18.9%) 30 (48.4%)
Antibacterial drug use during the last 6 months
Yes 41 (22.5%) 0.40 27 (57.5%) 0.34
No 63 (19.4%) 28 (48.3%)
Hospitalization during the last 6 months
Yes 81 (21.8%) 0.24 28 (70.0%) 0.005
No 23 (17.0%) 27 (41.5%)
Recent surgery
Yes 69 (22.6%) 0.14 21 (63.6%) 0.11
No 35 (17.3%) 34 (47.2%)
Family member working in healthcare setting
Yes 21 (20.2%) 0.92 9 (39.1%) 0.15
No 83 (20.6%) 46 (56.1%)
Smoking habit
Yes 19 (20%) 0.18 8 (72.7%) 0.15
No 85 (20.6%) 47 (50.0%)
Skin and soft tissue infection
Yes 16 (25%) 0.34 7 (50%) 0.84
No 88 (19.9%) 48 (52.7%)
Pneumonia
Yes 18 (17.1%) 0.33 7 (70%) 0.40
No 86 (21.4%) 48 (50.5%)
Urinary tract infections
Yes 0 — 0 —
No 104 (20.6%) 55 (52.4%)
Joint disease/osteoarthritis
Yes 0 — 0 —
No 104 (20.6%) 55 (52.4%)
Cancer
Yes 45 (26.6%) 0.016 0 —
No 59 (17.5%) 55 (52.4%)
Digestive disease
Yes 0 0.58 0 —
No 104 (20.7%) 55 (52.4%)
Hypertension
Yes 19 (17.1%) 0.31 43 (51.2%) 0.62
No 85 (21.5%) 12 (57.1%)
Heart disease
Yes 4 (17.4%) 0.70 0 —
No 100 (20.7%) 55 (52.4%)
Diabetes mellitus
Yes 13 (17.3%) 0.46 11 (61.1%) 0.41
No 91 (21.1%) 44 (50.6%)
Data are number (%) of patients.
Bold and underlined figures indicate statistically significant values (p < 0.05).
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admitted to the general hospital, S. aureus nasal carrier status
was significantly associated with cancer, whereas within
nephrology patients the carrier status was associated with
previous hospitalization (Table 1).
Out of the patients under study nine (1.5%) carried MRSA,
whereas the remaining 150 (24.5%) carried methicillin-
susceptible S. aureus (MSSA). Four MRSA isolates were
identified in the patients admitted to the nephrology depart-
ment and five among those admitted at the Amizour hospital.
Epidemiological, molecular characteristics and resistance
pattern of MRSA strains are summarized in Table 2. Re-
sistance to non b-lactam antibiotics was restricted to tetracy-
cline, aminoglycosides, or sulfamethoxazole-trimethoprim.
Only one ST80-IVc isolate was resistant to erythromycin.
Eight out of nine isolates carried a SCCmec type IV, with
four isolates carrying the subtype IVc. Four isolates belonged
to ST80, whereas ST22 and ST5 included two isolates each.
The remaining one was assigned to ST535 (clonal complex
[CC]30) and carried a SCCmec IVh. Three ST80-MRSA
isolates tested positive for the PVL genes. The tst1 gene was
present only in the ST22-MRSA isolates.
The MLVF analysis suggested a possible clonal relation
between the two strains (isolates 165 and 414) since no
difference in their electrophoretic profiles was observed. spa
typing assigned both isolates to spa type t223. These two
isolates were from two elderly patients admitted to the de-
partment of internal medicine of Amizour hospital.
Discussion
Scientific data on nasal carriage of S. aureus and MRSA
in Algeria are erratic and are lacking in the individuals in the
community. To our best knowledge, this is the first study
exclusively dedicated to assess nasal carriage of MSSA and
MRSA in Algeria.
Our S. aureus colonization rate was very close to the av-
erage rates detected in previous investigations conducted in
different countries around the world. Studies on patients re-
cently admitted to different care facilities in various countries
have shown colonization rates ranging from 21.5%5 or 23.7%
in the United States,14 to 22.1% in Taiwan,35 and 28.9% in
Australia.27 These rates were also varying within the same
country. For instance, in the United States higher figures than
those previously cited were reported in Hawaii and Georgia
with rates as high as 39.9% and 32.4%, respectively.16,20 It is
possible that differences in patients case mix could account for
most of these fluctuations.
According with literature, our study detected remarkably
different nasal colonization rates within the two subgroups
of patients under investigation, with a higher rate among
patients admitted to the nephrology department. Chronic
kidney failure is unanimously recognized to be a high risk
condition for carriage and disease by S. aureus.22,32 These
patients are, indeed, generally submitted to hemodialysis, a
healthcare procedure that is agreed as a major risk factor,
mainly because of progressive worsening of general health
conditions, application of invasive devices (catheters and
fistulas), and frequent underlying disease.18,21,22 Moreover,
in our experience S. aureus carriage proved to be signifi-
cantly associated in this subgroup of patients with previous
hospitalization, a recurrent event in the clinical course of
subjects affected by kidney failure.22,32 We also found that
cancer was associated with colonization by S. aureus in the
patients admitted to the Amizour general hospital, as a
probable consequence of immunological suppression. In
recent literature no report is available about this association.
Conversely, variables known to behave as risk factors, such
as male gender, young age, and smoking habits, did not
influence nasal carriage of S. aureus in our setting.13,16,20
The rate of MRSA carriage in our study was close to those
reported in countries with low incidence of nasal coloniza-
tion, such as Australia and The Netherlands with 0.7% and
0.03%, respectively.27,37 This rate is also lower than that
reported from Taiwan,35 France,9 and Slovenia34 with rates
of 3.8%, 14.6%, and 11.8%, respectively, and in some re-
gions of the United States, as in the states of Texas and
Georgia, with rates 3.4% and 7.3%, respectively.5,14 The low
MRSA carriage prevalence did not allow us to evaluate a
possible favoring role of demographic or clinical variables.
MLST analysis determined that four MRSA isolates were
ST80, all carrying SCCmec IV, and three encoding PVL genes.
This was expected in consideration of the dominant role of
this clone in staphylococcal infections in Algeria. In previous
studies on MRSA infections among children, newborns, and
their mothers, indeed, this clone represented 96.5% of the
isolates.6,7 This clone is also known to be frequent in North
Table 2. Epidemiological and Molecular Characteristics, and Resistance Pattern
of Methicillin-Resistant Staphylococcus aureus Strains Isolated from Community
Patients Admitted in Two Healthcare Institutions in Algeria (April 2010 to June 2012)
Strain code Ward Gender/age (years) SCCmec type pvl/tst1 genes ST Resistance patterna
25 Internal medicine F/38 IVc - / - 5 TOB, GEN
148 Surgery M/75 IVa - / - 80 TOB, GEN
165 Internal medicine F/71 IVa - / + 22 TOB, SXT
193 Surgery F/29 IVc + / - 80 TE
414 Internal medicine F/37 IVa - / + 22 TOB, SXT
248 Nephrology M/67 IVc + / - 80 ERY
257 Nephrology M/35 IVc + / - 80 TOB, GEN
296 Nephrology F/67 VII - / - 5 TE
322 Nephrology F/32 IVh - / - 535 TOB, TE
aOnly the resistances to non b-lactam antibiotics are included.
ERY, erythromycin; GEN, gentamycin; pvl, genes coding for Panton-Valentine leukocidin (PVL); SCCmec, staphylococcal cassette
chromosome mec element; ST, sequence type; SXT, trimethoprim/sulfamethoxazole; TE, tetracycline; TOB, tobramycin.
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African andMiddle East countries such as Tunisia, Jordan, and
Kuwait.1,17,31 However, the heterogeneity of the MRSA strains
isolated in this study was to some extent a surprising finding
compared to the large predominance of ST80-IV in the pre-
ceding investigations. Noteworthy, the two tst1 positive ST22-
MRSA-IV strains, spa type t223, appeared to be similar to the
‘‘Gaza strain,’’ the predominant MRSA clone in healthy chil-
dren and their parents living in the Gaza strip.2 This CC22-
MRSA-IV ‘‘Middle Eastern Variant’’ has been also described
in Jordan and Saudi Arabia,17,26 and more recently, in new-
borns and preschool children in Palermo, Italy.10,11 The de-
tection of this clone in Algeria confirms its wide dissemination
in the Mediterranean and Middle East area. Moreover, within
the two strains of ST5-MRSA, one could be identified as be-
longing to the so-called pediatric clone, which is widespread
across America, Europe, Asia, and Australia, but is apparently
infrequent in Africa.25 The ST5-MRSA-VII is, on the contrary,
an uncommonly identified strain, as reported by Monecke
et al.25 Finally, the ST535-MRSA-IVh strain belonged to
CC30, an important and worldwide spread clonal complex.
This study has some limitations. First, the epidemiologi-
cal and clinical data about patients were relatively lim-
ited, mainly about the previous history of exposure to the
healthcare system. Moreover, the descriptive design of the
study was unable to support a more accurate analysis of
the association of the variables under study with the S. aureus
carriage. The infection status as a possible outcome was not
investigated. However, our study provides for the first time
information about S. aureus and MRSA nasal carriage in
patients at admission to hospital in Algeria and about mo-
lecular characteristics of MRSA strains. S. aureus carriage,
either present at admission to the hospital or acquired during
hospitalization, increases the risk for infection. So, the
findings of this study could provide helpful hints for more
adequate patient management, especially in the case of those
suffering from renal failure and cancer, and for the infection
control programs in this country. Moreover, the phenotypic
and molecular characteristics of the MRSA isolates can
contribute to the worldwide map of this pathogen.
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